BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 16263717)

  • 41. Selective inhibition of prolactin gene transcription by the ETS-2 repressor factor.
    Day RN; Liu J; Sundmark V; Kawecki M; Berry D; Elsholtz HP
    J Biol Chem; 1998 Nov; 273(48):31909-15. PubMed ID: 9822660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GABP cooperates with c-Myb and C/EBP to activate the neutrophil elastase promoter.
    Nuchprayoon I; Simkevich CP; Luo M; Friedman AD; Rosmarin AG
    Blood; 1997 Jun; 89(12):4546-54. PubMed ID: 9192779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction between PU.1 and another Ets family transcription factor promotes macrophage-specific Basal transcription initiation.
    Ross IL; Yue X; Ostrowski MC; Hume DA
    J Biol Chem; 1998 Mar; 273(12):6662-9. PubMed ID: 9506963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and characterization of the IKKalpha promoter: positive and negative regulation by ETS-1 and p53, respectively.
    Gu L; Zhu N; Findley HW; Woods WG; Zhou M
    J Biol Chem; 2004 Dec; 279(50):52141-9. PubMed ID: 15469934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage.
    Anderson MK; Hernandez-Hoyos G; Diamond RA; Rothenberg EV
    Development; 1999 Jun; 126(14):3131-48. PubMed ID: 10375504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of B cell linker protein transcription by PU.1 and Spi-B in murine B cell acute lymphoblastic leukemia.
    Xu LS; Sokalski KM; Hotke K; Christie DA; Zarnett O; Piskorz J; Thillainadesan G; Torchia J; DeKoter RP
    J Immunol; 2012 Oct; 189(7):3347-54. PubMed ID: 22956576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat.
    Dekoninck A; Calomme C; Nizet S; de Launoit Y; Burny A; Ghysdael J; Van Lint C
    Oncogene; 2003 May; 22(19):2882-96. PubMed ID: 12771939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myb and Ets proteins cooperate in transcriptional activation of the mim-1 promoter.
    Dudek H; Tantravahi RV; Rao VN; Reddy ES; Reddy EP
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1291-5. PubMed ID: 1741383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. C/EBPepsilon directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters.
    Verbeek W; Gombart AF; Chumakov AM; Müller C; Friedman AD; Koeffler HP
    Blood; 1999 May; 93(10):3327-37. PubMed ID: 10233885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
    Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
    Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genome-wide comparison of PU.1 and Spi-B binding sites in a mouse B lymphoma cell line.
    Solomon LA; Li SK; Piskorz J; Xu LS; DeKoter RP
    BMC Genomics; 2015 Feb; 16(1):76. PubMed ID: 25765478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ets-1 protects vascular smooth muscle cells from undergoing apoptosis by activating p21WAF1/Cip1: ETS-1 regulates basal and and inducible p21WAF1/Cip: ETS-1 regulates basal and inducible p21WAF1/Cip1 transcription via distinct cis-acting elements in the p21WAF/Cip1 promoter.
    Zhang C; Kavurma MM; Lai A; Khachigian LM
    J Biol Chem; 2003 Jul; 278(30):27903-9. PubMed ID: 12740370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual regulation of ets-activated gene expression by SP1.
    Kelley KM; Wang H; Ratnam M
    Gene; 2003 Mar; 307():87-97. PubMed ID: 12706891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation.
    Brown C; Gaspar J; Pettit A; Lee R; Gu X; Wang H; Manning C; Voland C; Goldring SR; Goldring MB; Libermann TA; Gravallese EM; Oettgen P
    J Biol Chem; 2004 Mar; 279(13):12794-803. PubMed ID: 14715662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cooperative binding of c-Myb and Pax-5 activates the RAG-2 promoter in immature B cells.
    Kishi H; Jin ZX; Wei XC; Nagata T; Matsuda T; Saito S; Muraguchi A
    Blood; 2002 Jan; 99(2):576-83. PubMed ID: 11781241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcriptional regulation of mouse mu opioid receptor gene by PU.1.
    Hwang CK; Kim CS; Choi HS; McKercher SR; Loh HH
    J Biol Chem; 2004 May; 279(19):19764-74. PubMed ID: 14998994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of gene expression by transcription factors Ets-1 and Ets-2.
    Tymms MJ; Kola I
    Mol Reprod Dev; 1994 Oct; 39(2):208-14. PubMed ID: 7826624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myb binding sites mediate negative regulation of c-myb expression in T-cell lines.
    Guerra J; Withers DA; Boxer LM
    Blood; 1995 Sep; 86(5):1873-80. PubMed ID: 7655015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
    Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W
    Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The human caspase-8 promoter sustains basal activity through SP1 and ETS-like transcription factors and can be up-regulated by a p53-dependent mechanism.
    Liedtke C; Groger N; Manns MP; Trautwein C
    J Biol Chem; 2003 Jul; 278(30):27593-604. PubMed ID: 12748179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.